Beating sickle cellCharlotte ObserverKatlin suffered from sickle cell anemia and underwent a stem cell transplant from her father. She is able to participate in many normal teen activities without the debilitating pain she formerly felt. PHOTOS BY Jeff…
Study Gives Slight Edge to R-DHAP for B-Cell Lymphoma Subtype – Clinical Oncology News
Clinical Oncology NewsStudy Gives Slight Edge to R-DHAP for B-Cell Lymphoma SubtypeClinical Oncology NewsWhen CORAL was first presented, not only were we disappointed that neither R-ICE nor R-DHAP proved superior, we were devastated to learn how poorly…
Rally for organ donation tomorrow – Indian Express
Indian ExpressRally for organ donation tomorrowIndian ExpressTo encourage people to come forward to donate organs and spread awareness, a bicycle rally will be organised by Global Organ Donation Awareness Society (GLODAS) and Cycle Parts Association, L…
Sustained-release and combination therapies may be future of retinal treatment – OSN SuperSite
OSN SuperSiteSustained-release and combination therapies may be future of retinal treatmentOSN SuperSite“The steroid is kind of like a shotgun, whereas the anti-VEGFs, Lucentis and Avastin, are like sniper bullets,” Dr. Haller said, noting that cor…
Everolimus Touted As Game Changer In Breast Cancer – Clinical Oncology News
Clinical Oncology NewsEverolimus Touted As Game Changer In Breast CancerClinical Oncology NewsAdding everolimus (Afinitor, Novartis) to exemestane therapy improved progression-free survival (PFS) by four months compared with therapy with exemestane alo…
Experimental drug suppresses rebound of hepatitis C virus in liver transplant … – EurekAlert (press release)
Experimental drug suppresses rebound of hepatitis C virus in liver transplant …EurekAlert (press release)San Francisco — A human monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) given to patien…
Mistral Ventures Inc. (MILV); Subsidiary Signs another Agreement – SmallCap Network
Mistral Ventures Inc. (MILV); Subsidiary Signs another AgreementSmallCap NetworkMistral Ventures' subsidiary, Nature's Bioceuticals as announced that it executed the formal closing documents and acquired the chronic kidney disease formula, whic…
Health of Recipients and Quality of Donor are Greater Factors in Survival than … – PR Newswire (press release)
Health of Recipients and Quality of Donor are Greater Factors in Survival than …PR Newswire (press release)It is also growing as an indication for liver transplantation. Researchers from the University of California – San Francisco concluded in the…
Study Calls for Modification of CMS Conditions of Participation to Preserve … – PR Newswire (press release)
Study Calls for Modification of CMS Conditions of Participation to Preserve …PR Newswire (press release)4, 2011 /PRNewswire/ — Adherence to strict outcome requirements imposed by the Centers for Medicare and Medicaid Services (CMS) has an adverse ef…
Pfizer To Present Clinical Data From Its Hematology Portfolio At The 53rd … – MarketWatch (press release)
Pfizer To Present Clinical Data From Its Hematology Portfolio At The 53rd …MarketWatch (press release)(13,14) Inotuzumab is currently being evaluated in a Phase 3 study in combination with rituximab in patients with relapsed or refractory CD22-positi…